C4 Therapeutics, Inc. - COM STK (CCCC)

Historical Portfolio Holders from Q4 2020 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM STK
Shares, excl. options Q1 2024
57.9 M
Holdings value Q1 2024
$473 M
Value change Q1 2024
+$92.3 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
100
Number of buys Q1 2024
0
Number of sells Q1 2024
-2
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0%
CUSIP
12529R107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 600 $2.77 K -$975 K $4.62 1
2024 Q1 57.9 M $473 M +$92.3 M $8.17 101
2023 Q4 46.9 M $265 M +$85.4 M $5.65 90
2023 Q3 34.6 M $64.3 M -$105 K $1.86 81
2023 Q2 34.1 M $93.7 M -$9.39 M $2.75 93
2023 Q1 37.3 M $117 M -$15.2 M $3.14 116
2022 Q4 39.1 M $231 M -$9.78 M $5.90 109
2022 Q3 39.3 M $345 M -$2.32 M $8.77 111
2022 Q2 38.8 M $292 M -$38.9 M $7.54 107
2022 Q1 36.5 M $885 M +$12.9 M $24.26 114
2021 Q4 34.9 M $1.12 B -$5.06 M $32.20 115
2021 Q3 34.5 M $1.54 B +$109 M $44.68 110
2021 Q2 31.7 M $1.2 B +$250 M $37.84 106
2021 Q1 25.1 M $926 M +$90 M $36.99 82
2020 Q4 22.7 M $743 M +$718 M $33.13 74